HomeClinical Trials
Finding and Understanding Clinical Trials
A clinical study examines the effectiveness of new treatments and provides doctors and researchers with data to develop and deliver new, more effective treatments. In a typical year, over one million people participate in clinical studies.
This site provides essential clinical trial information: how medical trials work; your rights as a participant; and learn how signing up for trials can provide access to the best medical facilities and specialists. Participate in a clinical study and you'll help not only yourself, but also the thousands of others who could benefit from the trial's results.
Find a Trial...
You can use this site to find clinical trials by location or by medical condition; see below. Also, by using the search box on the right of this page, you can narrow your search to zip code level.
Current Clinical Trial Listings:
Search results for Lymphoma AND Recruiting
1)
Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell LymphomaLymphoma
2)
17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's LymphomaLymphoma
3)
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell LymphomasFollicular Lymphoma; Marginal Zone B-Cell Lymphoma; MALT Lymphoma; Lymphoma of Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Lymphocytic; Waldenstrom Macroglobulinemia; Mantle-Cell Lymphoma
4)
Non-Randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent LymphomaLymphoma; Non-Hodgkin Lymphoma
5)
Study of Oral LBH589 in Patients With Cutaneous T-Cell Lymphoma and Adult T-Cell Leukemia/LymphomaCutaneous T-Cell Lymphoma; Leukemia-Lymphoma, Adult T-Cell
6)
Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Treating Patients With Stage III or Stage IV Follicular Lymphoma or Marginal Zone LymphomaLymphoma
7)
Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or VorinostatHodgkin's Lymphoma; Low Grade Lymphoma; Lymphoma; Mantle Cell Lymphoma; Non-Hodgkin's Lymphoma; Diffuse Large Cell Lymphoma
8)
Flavopiridol in Treating Patients With Refractory or Recurrent Mantle Cell Lymphoma or Diffuse Large B-Cell LymphomaLymphoma
9)
Cardiac Magnetic Resonance Imaging in Patients With Newly Diagnosed Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving DoxorubicinCancer-Related Problem/Condition; Lymphoma
10)
Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent LymphomaLymphoma
11)
Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-Cell Lymphoma With Neuromeningeal Invasion at DiagnosisLymphoma, Non-Hodgkin; Diffuse Large B-Cell Lymphoma
12)
Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, or Relapsed B-Cell Non-Hodgkin LymphomaLeukemia; Lymphoma
13)
Oral Clofarabine for Relapsed/Refractory Non-Hodgkin LymphomasNon-Hodgkin's Lymphoma; Follicular Lymphoma; Marginal Zone Lymphoma; Mantle Cell Lymphoma; Small Lymphocytic Lymphoma; Lymphoplasmacytic Lymphoma; Diffuse Large B-Cell Lymphoma; T-Cell Lymphomas
14)
Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOPPeripheral T Cell Lymphoma, Unspecified; Angioimmunoblastic Lymphadenopathy; AIL Type Lymphoma; Anaplastic Large Cell Lymphoma, ALK Negative; Extranodal NK/T-Cell Lymphoma
15)
Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's LymphomaLeukemia; Lymphoma
16)
Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin LymphomaLymphoma
17)
Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's-Like Leukemia/LymphomaBurkitt's Lymphoma; Burkitt's-Like Lymphoma
18)
Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell LymphomaLymphoma
19)
Rituximab After Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in Mantle Cell LymphomaLymphoma, Mantle-Cell
20)
First-Line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.Follicular Lymphoma; Marginal Zone Lymphoma; Small Lymphocytic Lymphoma; Lymphoplasmacytic Lymphoma
